Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Nucleus Freedom Cochlear Implant System Pediatric Post-approval Study

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Cochlear
ClinicalTrials.gov Identifier:
NCT00589511
First received: December 23, 2007
Last updated: August 7, 2014
Last verified: August 2014

December 23, 2007
August 7, 2014
October 2006
June 2009   (final data collection date for primary outcome measure)
  • IT-MAIS [ Time Frame: 12 Months ] [ Designated as safety issue: No ]
  • MAIS [ Time Frame: 12 Months ] [ Designated as safety issue: No ]
  • MLNT [ Time Frame: 12 Months ] [ Designated as safety issue: No ]
  • LNT [ Time Frame: 12 Months ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00589511 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Nucleus Freedom Cochlear Implant System Pediatric Post-approval Study
Not Provided

The objective of this multisite study is to evaluate the performance of the Nucleus Freedom cochlear implant system in a large population of sequentially implanted pediatric subjects.

The proposed study will include 50 pediatric subjects ages 1 year to 17 years, 11 months of age, implanted at up to 5 sites in the United States and Canada. The estimated duration of this multisite study is 18 to 24 months. The duration of individual subject participation is not to exceed 12 months.

The study will be conducted as a within-subject repeated measures experiment (in which each subject serves as his or her own control) in order to accommodate the heterogeneity that is well known to characterize hearing-impaired populations

Observational
Observational Model: Case-Only
Not Provided
Not Provided
Non-Probability Sample

Children with bilateral severe to profound sensorineural hearing loss who undergo implantation with the Nucleus Freedom Cochlear Implant System

Sensorineural Hearing Loss
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
69
June 2009
June 2009   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • 1 year to 17 years, 11 months of age.
  • Bilateral severe to profound sensorineural hearing loss for those 1 to 2 years of age. Severe hearing loss for those 2 years of age and older.
  • Limited benefit from bilateral hearing aids. Limited benefit is defined as a lack of progress in the development of simple auditory skills in conjunction with appropriate amplification and intensive aural rehabilitation over a 3 to 6 month period.

    • For younger children, unable to take speech perception tests due to age-related cognitive and linguistic limitations, limited benefit will be quantified using the Infant Toddler Meaningful Auditory Integration Scale (IT-MAIS)1 or Meaningful Auditory Integration Scale (MAIS)1.
    • For older children, capable of speech perception tasks, limited benefit is defined as £ 30% on the recorded open-set Multisyllabic Lexical Neighborhood Test (MLNT)2 or Lexical Neighborhood Test (LNT) 2, depending on the child's cognitive and linguistic skills.
  • English spoken as a primary language.
  • Willingness to participate in and to comply with all requirements of the protocol.

Exclusion Criteria:

  • Ossification or any other cochlear anomaly that might prevent complete insertion of the electrode array, as confirmed by medical examination and tests including MRI.
  • Signs of retrocochlear or central origin to hearing impairment as confirmed by medical examination and tests including MRI.
  • Medical or psychological conditions that would contraindicate undergoing surgery (e.g., active middle ear infections, tympanic membrane perforation).
  • Additional handicaps that would prevent or restrict participation in the evaluations.
  • Unrealistic expectations on the part of the subject or subject's parents/guardians, regarding the possible benefits, risks and limitations that are inherent to the surgical procedure and prosthetic device.
  • Unwillingness or inability of the candidate or candidate's parents/guardians to comply with all study requirements.
Both
1 Year to 18 Years
No
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
NCT00589511
CORP5183
Not Provided
Cochlear
Cochlear
Not Provided
Not Provided
Cochlear
August 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP